F., major classes of drugs are currently used to treat glaucoma: beta-adrenergic blockers,
carbonic anhydrase inhibitors, sympathomimetics, and parasympathomimet-ics. Both local …

We undertook a non-concurrent prospective study of 191 Puerto Rican patients from August
1993 to April 1994. All patients had open angle glaucoma (OAG)(age ranged from 50 to 80 …

The safety profile of the different glaucoma medications is an important issue when initiating
therapy in glaucomatous patients. The decision on which medication to prescribe depends …

Glaucoma is a chronic, progressive disease in which retinal ganglion cells disappear and
subsequent, gradual reductions in the visual field ensues. Glaucoma eye drops have …

The use of any active pharmacological agent invariably is associated with unwanted
occurrences to which we give the name side effects or adverse effects. In some cases, these …

Glaucoma comprises a heterogeneous group of diseases that have in common a
characteristic optic neuropathy and visual field defects, for which elevated intraocular …

Purpose: To develop a Physicians' Guide to assist clinicians in the concomitant use of
glaucoma and systemic medications. Methods: The records of 100 consecutive patients with …

Aim To identify the relative incidence and profile of adverse drug reaction (ADR) to various
topical ocular hypotensives in a hospital setting. Methods All the patients presenting in …

Glaucoma, whether spontaneous or drug-induced, is caused in nearly all instances by
abnormal resistance to outflow of aqueous humor to the veins on the outer surface of the …

IN A PERFECT WORLD, THE EFFICACY OF THERAPEUTIC agents for glaucoma would be
determined through large, well-planned, randomized controlled trials (RCTs), placebo …